EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microfluidic-based systems for the management of diabetes

Shuyu Zhang iD, Anne E Staples iD

Drug Delivery and Translational Research · 2024

DOI: 10.1007/s13346-024-01569-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, 2024. Verfasst von Shuyu Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Blacksburg, VA, 24061, USA. shuyu@vt.edu. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Insulin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Virginia Polytechnic Institute and State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes currently affects approximately 500 million people worldwide and is one of the most common causes of mortality in the United States. To diagnose and monitor diabetes, finger-prick blood glucose testing has long been used as the clinical gold standard. For diabetes treatment, insulin is typically delivered subcutaneously through cannula-based syringes, pens, or pumps in almost all type 1 diabetic (T1D) patients and some type 2 diabetic (T2D) patients. These painful, invasive approaches can cause non-adherence to glucose testing and insulin therapy. To address these problems, researchers have developed miniaturized blood glucose testing devices as well as microfluidic platforms for non-invasive glucose testing through other body fluids. In addition, glycated hemoglobin (HbA1c), insulin levels, and cellular biomechanics-related metrics have also been considered for microfluidic-based diabetes diagnosis. For the treatment of diabetes, insulin has been delivered transdermally through microdevices, mostly through microneedle array-based, minimally invasive injections. Researchers have also developed microfluidic platforms for oral, intraperitoneal, and inhalation-based delivery of insulin. For T2D patients, metformin, glucagon-like peptide 1 (GLP-1), and GLP-1 receptor agonists have also been delivered using microfluidic technologies. Thus far, clinical studies have been widely performed on microfluidic-based diabetes monitoring, especially glucose sensing, yet technologies for the delivery of insulin and other drugs to diabetic patients with microfluidics are still mostly in the preclinical stage. This article provides a concise review of the role of microfluidic devices in the diagnosis and monitoring of diabetes, as well as the delivery of pharmaceuticals to treat diabetes using microfluidic technologies in the recent literature. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsInsulinHumansAnimalsMicrofluidic Analytical TechniquesBlood GlucoseMicrofluidicsLab-On-A-Chip DevicesDiabetes Mellitus, Type 2Diabetes MellitusDiabetes Mellitus, Type 1Drug Delivery Systems

Stichwörter der Autor:innen

DiabetesDrug deliveryGlucose monitoringGlycated hemoglobinInsulinMetforminMicrofluidicsMicroneedle array

Substanzen

Hypoglycemic AgentsInsulinBlood Glucose

Autor:innen und Institutionen

  • Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Blacksburg, VA, 24061, USA. shuyu@vt.edu.
  • Department of Biomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA, 24061, USA. shuyu@vt.edu.
  • Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Blacksburg, VA, 24061, USA.
  • Department of Biomedical Engineering and Mechanics, Virginia Tech, Blacksburg, VA, 24061, USA.

ORCID-Profile: Shuyu Zhang, Anne E Staples

Förderung

  • Virginia Polytechnic Institute and State University

Zitieren

APA

Zhang, S., & Staples, A. E. (2024). Microfluidic-based systems for the management of diabetes. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01569-y

Vancouver

Zhang S, Staples AE. Microfluidic-based systems for the management of diabetes. Drug Delivery and Translational Research. 2024. doi:10.1007/s13346-024-01569-y

BibTeX
@article{Zhang2024,
  author = {Zhang, Shuyu and Staples, Anne E},
  title = {Microfluidic-based systems for the management of diabetes},
  journal = {Drug Delivery and Translational Research},
  year = {2024},
  doi = {10.1007/s13346-024-01569-y}
}
Kostenlos starten →